{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:49:08Z","timestamp":1792234148431,"version":"4.4.0"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Project for conceptual development of research organisation Motol University Hospital","award":["00064203"],"award-info":[{"award-number":["00064203"]}]},{"name":"University Medical Centre Ljubljana","award":["20210007"],"award-info":[{"award-number":["20210007"]}]},{"name":"Grantov\u00e1 Agentura, Univerzita Karlova","award":["210322"],"award-info":[{"award-number":["210322"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is a severe, genetically determined neuromuscular disorder characterised by progressive muscle weakness resulting from motor neuron degeneration. Although therapies such as nusinersen have altered disease trajectories, objective biomarkers for treatment monitoring remain lacking. Neurofilament proteins, particularly phosphorylated neurofilament heavy chain (pNFH), are promising candidates for this role.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate pNFH levels in cerebrospinal fluid (CSF) and serum as potential biomarkers for monitoring treatment response to nusinersen in paediatric patients with SMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This two-center observational study involved 56 SMA patients (types I\u2013III) treated with nusinersen and 30 age-matched controls. pNFH concentrations in CSF and serum were measured at predefined intervals using ELISA kits. Motor function was assessed with CHOP INTEND, HFMSE, or MFM scales at baseline and after 3, 6, and 12 months. Mixed linear regression modeling evaluated changes in neurofilament levels and motor function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline pNFH levels in both CSF and serum were significantly higher in SMA patients compared to controls. Following nusinersen therapy, pNFH levels decreased significantly in both compartments, especially in the first 6 months. Younger patients had higher initial serum pNFH levels. A significant correlation was found between CSF and serum pNFH concentration. An association between pNFH levels and motor scores was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>pNFH levels in CSF and serum show potential as objective biomarkers for monitoring the initial treatment response in paediatric SMA. Longitudinal changes are more informative than single measurements. Further validation in larger cohorts and using more sensitive methods is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/22143602261488135","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:26:11Z","timestamp":1792232771000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurofilaments in cerebrospinal fluid and\/or serum as a possible biomarker of pediatric spinal muscular atrophy"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4967-4797","authenticated-orcid":false,"given":"Mark\u00e9ta","family":"Kumhera","sequence":"first","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Vrs\u010daj","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Loboda","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damjan","family":"Osredkar","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana"},{"name":"University of Ljubljana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Holotov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Rohlenov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Lauerov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Jur\u00e1\u0161ov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Hanzalov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"},{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"Pavl\u00edkov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Haberlov\u00e1","sequence":"additional","affiliation":[{"name":"Charles University and Motol and Homolka University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2001.tb00395.x"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0314-x"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.2217\/fnl.13.58"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90847-8"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6307"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00001-6"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.447"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-693X(20)30276-1"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.779"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51449"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018309"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.03.015"},{"key":"e_1_3_8_19_2","first-page":"315406","article-title":"Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis","volume":"2011","author":"Gresle MM","year":"2011","unstructured":"Gresle MM, Butzkueven H, Shaw G. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int 2011; 2011: 315406. https:\/\/doi.org\/10.1155\/2011\/315406","journal-title":"Mult Scler Int"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199812010-00036"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28206"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11787-y"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215397"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1311"},{"key":"e_1_3_8_25_2","unstructured":"Agency EM. Letter of Support of Neurofilament light in childhood Neurological diseases. Reference number EMADOC-1700519818-959805. https:\/\/www.ema.europa.eu\/en\/documents\/other\/letter-support-neurofilament-light-childhood-neurological-diseases_en.pdf (2022)."},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.11.004"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51645"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.09.007"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09547-y"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa098"},{"issue":"7","key":"e_1_3_8_31_2","first-page":"1624","article-title":"Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord","volume":"125","author":"Soler-Botija C","year":"2002","unstructured":"Soler-Botija C, Ferrer I, Gich I, et al., Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord. Online. Brain. Ro\u010d. 2002; 125(7): 1624\u20131634. ISSN 14602156. https:\/\/doi.org\/10.1093\/brain\/awf155","journal-title":"Online. Brain. Ro\u010d"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0831-9"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00293"},{"issue":"23","key":"e_1_3_8_34_2","first-page":"00115","article-title":"Evaluation of the neurofilament light chain as a biomarker in children with spinal muscular atrophy treated with nusinersen [published online ahead of print, 2023 Aug 2]","volume":"0387","author":"Seo G","year":"2023","unstructured":"Seo G, Kim S, Byun JC, et al. Evaluation of the neurofilament light chain as a biomarker in children with spinal muscular atrophy treated with nusinersen [published online ahead of print, 2023 Aug 2]. Brain Dev 2023; S0387-7604(23): 00115\u201300118. https:\/\/doi.org\/10.1016\/j.braindev.2023.07.005","journal-title":"Brain Dev"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.982760"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8020021"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00256-2"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602261488135","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/22143602261488135","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602261488135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:26:13Z","timestamp":1792232773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/22143602261488135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":36,"alternative-id":["10.1177\/22143602261488135"],"URL":"https:\/\/doi.org\/10.1177\/22143602261488135","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"article-number":"22143602261488135"}}